These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12051944

  • 1. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
    Rowsell S, Hawtin P, Minshull CA, Jepson H, Brockbank SM, Barratt DG, Slater AM, McPheat WL, Waterson D, Henney AM, Pauptit RA.
    J Mol Biol; 2002 May 24; 319(1):173-81. PubMed ID: 12051944
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H, Werle K, Bauer MM, Dollinger H, Jung B.
    J Mol Biol; 2001 Sep 28; 312(4):743-51. PubMed ID: 11575929
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 4. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R.
    J Mol Biol; 2000 Sep 22; 302(3):671-89. PubMed ID: 10986126
    [Abstract] [Full Text] [Related]

  • 5. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K.
    J Mol Biol; 2001 Sep 28; 312(4):731-42. PubMed ID: 11575928
    [Abstract] [Full Text] [Related]

  • 6. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M.
    J Med Chem; 1999 May 20; 42(10):1723-38. PubMed ID: 10346925
    [Abstract] [Full Text] [Related]

  • 7. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
    Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F.
    J Med Chem; 2009 Feb 26; 52(4):1040-9. PubMed ID: 19173605
    [Abstract] [Full Text] [Related]

  • 8. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T, Hochigai H, Yamashita E, Tsukihara T, Kanaoka M.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):315-22. PubMed ID: 16603129
    [Abstract] [Full Text] [Related]

  • 9. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
    Pavlovsky AG, Williams MG, Ye QZ, Ortwine DF, Purchase CF, White AD, Dhanaraj V, Roth BD, Johnson LL, Hupe D, Humblet C, Blundell TL.
    Protein Sci; 1999 Jul 26; 8(7):1455-62. PubMed ID: 10422833
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structure of recombinant mouse collagenase-3 (MMP-13).
    Botos I, Meyer E, Swanson SM, Lemaître V, Eeckhout Y, Meyer EF.
    J Mol Biol; 1999 Oct 01; 292(4):837-44. PubMed ID: 10525409
    [Abstract] [Full Text] [Related]

  • 12. Potent "clicked" MMP2 inhibitors: synthesis, molecular modeling and biological exploration.
    Zapico JM, Serra P, García-Sanmartín J, Filipiak K, Carbajo RJ, Schott AK, Pineda-Lucena A, Martínez A, Martín-Santamaría S, de Pascual-Teresa B, Ramos A.
    Org Biomol Chem; 2011 Jun 21; 9(12):4587-99. PubMed ID: 21552627
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.
    Morales R, Perrier S, Florent JM, Beltra J, Dufour S, De Mendez I, Manceau P, Tertre A, Moreau F, Compere D, Dublanchet AC, O'Gara M.
    J Mol Biol; 2004 Aug 20; 341(4):1063-76. PubMed ID: 15289103
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL, Ruff M, Kannan R, Cuniasse P, Yiotakis A, Dive V, Rio MC, Basset P, Moras D.
    J Mol Biol; 2001 Mar 23; 307(2):577-86. PubMed ID: 11254383
    [Abstract] [Full Text] [Related]

  • 15. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M, Tordai H, Trexler M, Bányai L, Patthy L.
    Biochimie; 2005 Mar 23; 87(3-4):385-92. PubMed ID: 15781326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
    Hrmova M, Fincher GB.
    Carbohydr Res; 2007 Sep 03; 342(12-13):1613-23. PubMed ID: 17548065
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.
    Maskos K, Lang R, Tschesche H, Bode W.
    J Mol Biol; 2007 Mar 02; 366(4):1222-31. PubMed ID: 17196980
    [Abstract] [Full Text] [Related]

  • 20. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
    Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP.
    J Med Chem; 2004 Jun 03; 47(12):2981-3. PubMed ID: 15163180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.